Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae.
about
Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrheaThe use of cephalosporins for gonorrhea: the impending problem of resistanceCurrent and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challengeAntimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and futureRussian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.Single dose oral norfloxacin or intramuscular spectinomycin to treat gonorrhoea (PPNG and non-PPNG infections): analysis of efficacy and patient preference.Effect of penicillin and spectinomycin given for urethritis and cervicitis with Neisseria gonorrhoeae: high prevalence of penicillin-resistant isolatesAntibiotic treatment of gonorrhoea--clinical evidence for choiceSurveillance of antibiotic resistance in Neisseria gonorrhoeae in The Netherlands, 1977-95Spectinomycin resistance in Neisseria spp. due to mutations in 16S rRNA.Cephalosporin Resistance in Neisseria gonorrhoeae.In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogensAntimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone.Trends in susceptibility of Neisseria gonorrhoeae to ceftriaxone from 1985 through 1991Comparison of broth microdilution and agar dilution for susceptibility testing of Neisseria gonorrhoeaeSpectinomycin disk zone diameter as a predictor of outcome in clinical treatment of gonorrheaCurrent concepts in bacterial sexually transmitted diseases.A40926, a new glycopeptide antibiotic with anti-Neisseria activity.An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae.The prevalence and epidemiology of plasmid-mediated penicillin and tetracycline resistance among Neisseria gonorrhoeae isolates in Guangzhou, China, 2002-2012High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failureComparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women.Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future.Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea.Neisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway.Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies.Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy.Antimicrobial resistance in Neisseria gonorrhoeae and Treponema pallidum: evolution, therapeutic challenges and the need to strengthen global surveillanceSorting out the cephalosporins.Mutation in ribosomal protein S5 leads to spectinomycin resistance in Neisseria gonorrhoeae.Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century.Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial.Assessment of Etest as an alternative to agar dilution for antimicrobial susceptibility testing of Neisseria gonorrhoeaeGonococcal resistance: are cephalosporins next?The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting.The role of core groups in the emergence and dissemination of antimicrobial-resistant N gonorrhoeae.Evolving gonococcal antimicrobial resistance: research priorities and implications for management.Molecular epidemiology of gonorrhea.
P2860
Q24633203-E25FCFFD-2F55-4BD2-8713-B96A9A0225E8Q24656750-2BF6F5CC-6738-484B-9F8D-60EA4C27E8EBQ26796265-13459B9F-A09F-41F2-9A58-7FA8165F4595Q26862597-08BE5297-AD91-49E1-ADF0-4BF5B5E970FCQ33822930-F0C48CFE-0793-43F1-B42C-8827CC7FBB84Q33931752-BF103F52-5D5A-4DEE-A208-4EA8B542ABABQ33932305-1A3BBC9D-587F-410E-AE05-B12496490A89Q33936260-976D6A33-022D-4051-ABC9-FB5108F35926Q33937056-5AD9D9BD-33A9-4DB0-91B8-78141D9806E6Q33979545-6F289EC9-2C82-4024-B5B0-1E63E39F2893Q34159858-42E2342A-2377-4EC8-8213-13679618B7F9Q34626011-4B7CA1BB-AAC0-4C39-9209-39F0F48A7282Q34677116-531CDE90-F994-4766-A665-0E27D4A474F3Q35065794-A59FD444-C267-46F5-A9DB-94A68A8572D3Q35113566-B5AD04CC-D873-4D0E-8D9F-BFA84227B52FQ35244406-521D785F-DCE4-4284-8012-5C5EA64DB5B4Q35306543-A4C76B86-A587-4855-A9F9-8D73112067A3Q35407397-2B8A658F-A106-45B1-A38E-FCB99BD550BFQ35562929-8732C3A9-843A-4114-BB28-7EF5B603B32DQ35611039-8DDC1741-36A5-48CE-BD29-C6D2A60D9F12Q35802385-A168D66C-3595-4471-95B6-15DE9CDDBFC3Q35806206-9A7BD4B5-30CE-4411-9774-BFA26CEFE513Q35817931-0A9FADC8-A6C5-4FFD-8450-D72D8B7935A2Q35840879-B030B42E-5708-43E0-B77B-D3ADD13BE88AQ35878450-DEBBE46D-004B-4056-9F9C-B488273FB550Q35962785-CC3F1ACF-7CB1-40D3-A191-223E9387CDB0Q36558447-73104CFB-4B66-4662-9C74-C44706FB082BQ36607407-3E07507B-8BA5-49FC-A300-F8BBC8976D95Q36639438-3A8ECB79-8FB0-451C-B06A-7B4B28622402Q36723212-95D889F1-90BF-4399-9B68-82D9F4F1A5AFQ36771415-7709A541-7E56-4364-A2C0-5A6C64C72D91Q36998166-F4F5AE1E-FD2F-44B3-BFCC-FDBC6A110923Q37036002-67968769-0C22-4EE9-8223-38E480340227Q37436771-AFE1EF33-FE7F-4930-A418-A2A30FDB5FD6Q37713705-A1847C97-92CE-40DC-81B6-4C661D4324D0Q37848735-7C95324B-2E26-44C5-BB23-625947B1879BQ38011099-D942EA98-FCA9-4012-8CD4-BDBE44DE5415Q38163514-007CA1E1-0691-4F58-AE57-C4F13FC7DCA3Q38163515-68F459C2-2354-4BF3-B8AC-AFAEEB2AEB23Q38224751-BD8747C9-B6E3-4A9D-8F0F-A85DBA9F6665
P2860
Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
Effect of spectinomycin use on ...... oducing Neisseria gonorrhoeae.
@en
Effect of spectinomycin use on ...... oducing Neisseria gonorrhoeae.
@nl
type
label
Effect of spectinomycin use on ...... oducing Neisseria gonorrhoeae.
@en
Effect of spectinomycin use on ...... oducing Neisseria gonorrhoeae.
@nl
prefLabel
Effect of spectinomycin use on ...... oducing Neisseria gonorrhoeae.
@en
Effect of spectinomycin use on ...... oducing Neisseria gonorrhoeae.
@nl
P2093
P1476
Effect of spectinomycin use on ...... oducing Neisseria gonorrhoeae.
@en
P2093
Boslego JW
Diniega BM
Mitchell BS
Takafuji ET
Tramont EC
P304
P356
10.1056/NEJM198707303170504
P407
P577
1987-07-01T00:00:00Z